White label ELPA - ClinicalTrials.eu

Study of Bintrafusp Alfa and Doxorubicin Hydrochloride for Adults with Advanced Soft-Tissue Sarcoma

Not recruiting

2 1 1 1
Investigated diseases:
- Soft tissue sarcoma
Investigated drugs:
- Bintrafusp Alfa
- Doxorubicin Hydrochloride
Study of Sasanlimab and Sacituzumab Govitecan for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
Study of Pembrolizumab and Azacitidine for Patients with Acute Myeloid Leukemia Facing Imminent Relapse

Not recruiting

2 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Azacitidine
- Pembrolizumab
Study of Acalabrutinib Alone or with Rituximab for Patients with Relapsed/Refractory Marginal Zone Lymphoma

Not recruiting

1 1 1 1
Investigated diseases:
- B-cell lymphoma
Investigated drugs:
- Acalabrutinib
Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation

Not recruiting

1 1 1
Investigated diseases:
Investigated drugs:
- Romidepsin
Study on the Effectiveness of Sodium Chloride and Sodium Citrate in Intensive Care Patients Undergoing Continuous Kidney Purification

Not recruiting

3 1 1 1
Investigated diseases:
- Thrombosis prophylaxis
Investigated drugs:
- Sodium Citrate
- Sodium Chloride
Study of Durvalumab and Regorafenib for Patients with Stage IV Colorectal Cancer with No Evidence of Disease

Not recruiting

2 1 1 1
Investigated diseases:
- Adenocarcinoma of colon
Investigated drugs:
- Durvalumab
- Regorafenib
Study of Durvalumab, Carboplatin and Etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Neuroendocrine carcinoma metastatic
Investigated drugs:
Study of Pembrolizumab and Sacituzumab Govitecan for Patients with Muscle-Invasive Bladder Cancer Unable or Unwilling to Use Cisplatin-Based Chemotherapy

Not recruiting

2 1 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Sacituzumab Govitecan
- Pembrolizumab
Study on Slowing Advanced Puberty in Girls Using Metformin, Pioglitazone, and Spironolactone

Not recruiting

2 1
Investigated diseases:
- Precocious puberty
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies